Rosacea Relief

Article

Las Vegas - The FDA on Jan. 2 cleared Berlex Laboratories Inc. to market Finacea (azelaic acid 15 percent) gel for the treatment of rosacea.

Related Videos
Related Content

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023
© 2023 MJH Life Sciences

All rights reserved.